Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

Overview of attention for article published in Journal of Translational Medicine, December 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 1 X user
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMPOSITION FOR DIAGNOSIS, PREVENTION, OR TREATMENT OF GANGLIOGLIOMA AND DISEASE RELATED…

Application EP-3646868-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.